
### [NCIT:C3060](http://purl.obolibrary.org/obo/NCIT_C3060)
**Label:** Glomus Tumor

**Subclasses:** [NCIT:C51133](http://purl.obolibrary.org/obo/NCIT_C51133) (Solid Glomus Tumor), [NCIT:C27497](http://purl.obolibrary.org/obo/NCIT_C27497) (Glomus Tumor of Uncertain Malignant Potential), [NCIT:C6480](http://purl.obolibrary.org/obo/NCIT_C6480) (Bone Glomus Tumor), [NCIT:C95900](http://purl.obolibrary.org/obo/NCIT_C95900) (Gastric Glomus Tumor), [NCIT:C6748](http://purl.obolibrary.org/obo/NCIT_C6748) (Benign Glomus Tumor), [NCIT:C27496](http://purl.obolibrary.org/obo/NCIT_C27496) (Glomangiomatosis), [NCIT:C6750](http://purl.obolibrary.org/obo/NCIT_C6750) (Cutaneous Glomangioma), [NCIT:C4221](http://purl.obolibrary.org/obo/NCIT_C4221) (Malignant Glomus Tumor), [NCIT:C4222](http://purl.obolibrary.org/obo/NCIT_C4222) (Glomangioma), [NCIT:C4491](http://purl.obolibrary.org/obo/NCIT_C4491) (Glomus Tumor of the Skin), [NCIT:C5350](http://purl.obolibrary.org/obo/NCIT_C5350) (Hereditary Glomangioma), 

**Class expressions from DL-Learner:**

- [CL:0000669](http://purl.obolibrary.org/obo/CL_0000669) (pericyte cell) 57.14%
- [CL:0000630](http://purl.obolibrary.org/obo/CL_0000630) (supportive cell) 57.14%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C36966](http://purl.obolibrary.org/obo/NCIT_C36966) (Malignant Glomus Cell))) 57.14%
- Thing 52.12%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 42.50%
- [NCIT:C36965](http://purl.obolibrary.org/obo/NCIT_C36965) (Glomus Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 42.50%


